CFO Tobin Schilke sold $101K of Revance Therapeutics, Inc.

Sold$101,472

$31.70Price

3,201Shares

−5%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Mon, May 1. Filed Tue, May 2, 12:01 PM ET, during the session. Not investment advice.